Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients

Bone Marrow Transplantation

Volumn 20, Issue 12, 1997, Pages 1011-1017

  Oudshoorn, M ^a   Cornelissen, J J ^b   Fibbe, W E ^a   De Graeff Meeder, E R ^c   Lie, J L W T ^a   Schreuder, G M Th ^a   Sintnicolaas, K ^d   Willemze, R ^a   Vossen, J M J J ^a   Van Rood, J J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

Author keywords

BMT; Donor search; Unrelated donors

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BONE MARROW TRANSPLANTATION; CANADA; CHILD; DONOR; EUROPE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HLA MATCHING; HLA TYPING; HUMAN; HUMAN CELL; INDIA; INFANT; ISRAEL; MALE; NEW ZEALAND; NORTH AMERICA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; SOUTH AFRICA; VOLUNTEER;

EID: 0031464465     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701025     Document Type: Article

References (37)

1. Stroncek D. Results of bone marrow transplants from unrelated donors. Transfusion 1992; 32: 180-189.
2. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 595-602.
3. Van Rood JJ, van Leeuwen A, van den Tweel JG et al. Typing for the MLC determinants and its possible impact on Europdonor. Transplant Proc 1974; VI: 411-415.
4. McCullough J, Rogers G, Dahl R et al. Development and operation of a program to obtain volunteer bone marrow donors unrelated to the patient. Transfusion 1986; 26: 315-323.
5. McCullough J, Hansen JA, Perkins HA et al. The NMDP: how it works, accomplishments to date. Oncology 1989; 3: 63-72.
6. Cleaver SA. The Anthony Nolan Research Centre. Bone Marrow Transplant 1993; 11 (Suppl. 1): 38-40.
7. Stroncek D, Bartsch G, Perkins HA et al. The National Marrow Donor Program. Transfusion 1993; 33: 567-577.
8. Howard MR, Gore SM, Hows JM et al. A prospective study of factors determining the outcome of unrelated marrow donor searches: report from the International Marrow Unrelated Search and Transplant Study Working Group on behalf of collaborating centres. Bone Marrow Transplant 1994; 13: 389-396.
9. Anasetti C, Howe C, Petersdorf EW et al. Marrow transplants from HLA matched unrelated donors: an NMDP update and the Seattle experience. Bone Marrow Transplant 1994; 13: 693-695.
10. Ottinger H, Grosse-Wilde M, Schmitz A, Grosse-Wilde H. Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costs. Bone Marrow Transplant 1994; 14 (Suppl. 4): S34-S38.
11. Speiser DE, Tiercy J-M, Rufer N et al. Relation between the resolution of HLA-typing and the chance of finding an unrelated bone marrow donor. Bone Marrow Transplant 1994; 13: 805-809.
12. Hansen JA, Petersdorf EW, Yoon Choo S et al. Marrow transplantation from HLA partially matched relatives and unrelated donors. Bone Marrow Transplant 1995; 15 (Suppl. 1): S128-S139.
13. Schipper RF, D'Amaro J, Oudshoorn M. The probability of finding a suitable related donor for bone marrow transplant in extended families. Blood 1996; 87: 800-804.
14. Oudshoorn M, van Leeuwen A, van der Zanden HGM, van Rood JJ on behalf of the Editorial Board of BMDW. Bone Marrow Donors Worldwide. A successful exercise in international cooperation. Bone Marrow Transplant 1994; 14: 3-8.
15. Schipper RF, D'Amaro J, Oudshoorn M. The probability of finding a haplotypically identical unrelated bone marrow donor. Hum Immunol 1996 (submitted).
16. Van Rood JJ, van Leeuwen A, Ploem JS. Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature 1976; 262: 795-797.
17. Verduyn W, Doxiadis IIN, Anholts JDH et al. Biotinylated DRB sequence specific oligonucleotides, comparison to serologic HLA-DR typing of organ donors in Eurotransplant. Hum Immunol 1993; 37: 59-67.
18. Olerup O, Zetterquist H. HLA-DR typing by amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigen 1993; 39: 225-235.
19. Bunce M, O'Neill CM, Barnardo MCNM et al. Phenotyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP). Tissue Antigen 1995; 46: 355-367.
20. Keuning JJ, Termijtelen A, Blussé van Oud Alblas A et al. Typing for MLC (LD). Transplant Proc 1975; VII: 35-39.
21. Zhang L, Li S, Vandekerckhove B et al. Analysis of cytotoxic T cell precursor frequencies directed against individual HLA-A and -B alloantigens. J Immunol Meth 1989; 121: 39-45.
22. Schipper RF, Schreuder GMTh, D'Amaro J, Oudshoorn M. HLA and gene and haplotype frequencies in Dutch blood donors. Tissue Antigen 1996; 48: 562-574.
23. Beatty PG, Dahlberg S, Mickelson EM et al. Probability of finding HLA-matched unrelated marrow donors. Transplantation 1988; 45: 714-718.
24. Dini G, Lanino E, Lamparelli T et al. Unrelated donor marrow transplantation: initial experience of the Italian Bone Marrow Transplant Group (GITMO). Bone Marrow Transplant 1996; 17: 55-62.
25. Mickelson EM, Bartsch GE, Hansen JA et al. The MLC assay as a test for HLA-D region compatibility between patients and unrelated donors: results of a national marrow donor program involving multiple centers. Tissue Antigen 1993; 42: 465-472.
26. Segall M, Noreen H, Edwins L et al. Lack of correlation of MLC reactivity with acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation. Hum Immunol 1996; 49: 49-55.
27. Mickelson EM, Longton G, Anasetti C et al. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation. Tissue Antigen 1996; 47: 27-36.
28. Kaminski E, Hows J, Man S et al. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 1989; 48: 608-613.
29. Spencer A, Brookes PA, Kaminski E et al. Cytotoxic T lymphocyte precursor frequency analysis in bone marrow transplantation with volunteer unrelated donors. Transplantation 1995; 59: 1302-1308.
30. Speiser DE, Löliger C-C, Siren M-K et al. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT. Br J Haematol 1996; 93: 935-939.
31. Rufer N, Tiercy J-M, Breur-Vriesendorp B et al. Histoincompatibilities in ABDR-matched unrelated donor recipient combinations. Bone Marrow Transplant 1995; 16: 641-646.
32. Oudshoorn M, Falkenburg JHF, Ebeling LJ et al. Case Report: Unrelated bone marrow transplantation as a rescue procedure following inadvertent loss of an autologous bone marrow graft. Bone Marrow Transplant 1996; 18: 461-463.
33. Petersdorf EW, Perkins H, Sekiguchi S et al. Joint Report. Marrow transplantation. In: Tsuji K, Aizawa M, Sasazuki T (eds). HLA 1991, Vol. I. Oxford University Press: Oxford, 1992, pp 812-820.
34. Beatty PG, Mori M, Milford E. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation 1995; 60: 778-783.
35. Wagner JE, Kernan NA, Steinbuch M et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346: 214-219.
36. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. New Engl J Med 1996; 335: 157-166.
37. Gale RP, Mortin MM, van Bekkum DW et al. Risk factors for acute graft-vs-host disease. Br J Haematol 1987; 67: 397-406.